Publication | Open Access
Lupeol suppresses migration and invasion <i>via</i> p38/MAPK and PI3K/Akt signaling pathways in human osteosarcoma U-2 OS cells
42
Citations
35
References
2019
Year
Human Osteosarcoma CellsChemoprevention StrategyCancer BiologyTumor BiologySignaling PathwayCancer Cell BiologyAnti-cancer AgentNatural FoodsMatrix BiologyRadiation OncologyCell SignalingCancer ResearchMolecular SignalingMedicineCancer TreatmentPharmacologyCell BiologyOsteosarcoma Cell MetastasisTumor SuppressorOncologyCancer Growth
Lupeol, one of the common components from the fruits and natural foods, has been reported to exert antitumor activities in many human cancer cell lines; however, its effects on osteosarcoma cell metastasis were not elucidated. In the present study, lupeol at 10-25 μM induced cell morphological changes and decreased total viable cell number in U-2 OS cells. Lupeol (5-15 μM) suppressed cell mobility, migration, and invasion by wound healing and transwell chamber assays, respectively. Lupeol inhibited the activities of MMP-2 and -9 in U-2 OS cells by gelatin zymography assay. Lupeol significantly decreased PI3K, pAKT, β-catenin, and increased GSK3β. Furthermore, lupeol decreased the expressions of Ras, p-Raf-1, p-p38, and β-catenin. Lupeol also decreased uPA, MMP-2, MMP-9, and N-cadherin but increased VE-cadherin in U-2 OS cells. Based on these observations, we suggest that lupeol can be used in anti-metastasis of human osteosarcoma cells in the future.
| Year | Citations | |
|---|---|---|
Page 1
Page 1